Overview
Mika Mori practices in Kanazawa, Japan. Mori is rated as an Experienced expert by MediFind in the treatment of Defective Apolipoprotein B-100. Their top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Heart Tumor, and Heterozygous Familial Hypercholesterolemia (HeFH).
Their clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Defective Apolipoprotein B-100.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Hypercholesterolemia
- High CholesterolMori isAdvanced. Learn about High Cholesterol.
- Experienced
- Acute Coronary SyndromeMori isExperienced. Learn about Acute Coronary Syndrome.
- AtherosclerosisMori isExperienced. Learn about Atherosclerosis.
- Blood ClotsMori isExperienced. Learn about Blood Clots.
- Coronary Heart DiseaseMori isExperienced. Learn about Coronary Heart Disease.
- Defective Apolipoprotein B-100
- EndocarditisMori isExperienced. Learn about Endocarditis.